Send the following on WhatsApp
Continue to ChatFRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID https://invesbrain.com/frontier-biotechnologies-announces-positive-phase-1-results-of-its-first-coronavirus-main-protease-mpro-small-molecule-inhibitor-laying-foundation-for-the-treatment-of-acute-and-long-covid/